INCYTE CORPORATION
bd_ccdf4be11a4b5344 · schema v1 · pii pii-v1
Full breach record for INCYTE CORPORATION →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group DragonForce on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. You have been given clear instructions, reach out to us before it's too late.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Apr 21, 2026
- Raw hash
- daacaf290e25740c35646ad25c3aa23c68825b4ac3531b914ae2ed2c26b3ddaf
Reporting entity
- Name
- dragonforce
Victim entity
- Name
- INCYTE CORPORATIONnorm: incyte
- Domain
- incyte.com
- Industry
- Healthcarellm
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· dragonforce
- Threat actor
- DragonforceExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.